Apyx Medical is an energy technology company. In its Advanced Energy segment, Co.'s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Co.'s primary focus is on the cosmetic surgery market where Renuvion® provides plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue. In its Original Equipment Manufacturing (OEM) segment, Co. produces generators and related accessories for medical device manufacturers through OEM agreements, as well as start-up companies with the need for its energy-based designs. The APYX average annual return since 2019 is shown above.
The Average Annual Return on the APYX average annual return since 2019 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether APYX average annual return since 2019 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the APYX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|